MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.injury.2024.111523

Медицинская библиотека · Injury · 2024

Propensity weighted analysis of chemical venous thromboembolism prophylaxis agents in isolated severe traumatic brain injury: An EAST sponsored multicenter study.

Ratnasekera Asanthi M, Seng Sirivan S, Kim Daniel, Ji Wenyan, Jacovides Christina L, Kaufman Elinore J, Sadek Hannah M, Perea Lindsey L, Poloni Christina Monaco, Shnaydman Ilya, Lee Alexandra Jeongyoon, Sharp Victoria, Miciura Angela, Trevizo Eric, Rosenthal Martin G, Lottenberg Lawrence, Zhao William, Keininger Alicia, Hunt Michele, Cull John, Balentine Chassidy, Egodage Tanya, Mohamed Aleem T, Kincaid Michelle, Doris Stephanie, Cotterman Robert, Seegert Sara, Jacobson Lewis E, Williams Jamie, Moncrief Melissa, Palmer Brandi, Mentzer Caleb, Tackett Nichole, Hranjec Tjasa, Dougherty Thomas, Morrissey Shawna, Donatelli-Seyler Lauren, Rushing Amy, Tatebe Leah C, Nevill Tiffany J, Aboutanos Michel B, Hamilton David, Redmond Diane, Cullinane Daniel C, Falank Carolyne, McMellen Mark, Duran Chris, Daniels Jennifer, Ballow Shana, Schuster Kevin M, Ferrada Paula

СтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

BACKGROUND

In patients with severe traumatic brain injury (TBI), clinicians must balance preventing venous thromboembolism (VTE) with the risk of intracranial hemorrhagic expansion (ICHE). We hypothesized that low molecular weight heparin (LMWH) would not increase risk of ICHE or VTE as compared to unfractionated heparin (UH) in patients with severe TBI.

METHODS

Patients ≥ 18 years of age with isolated severe TBI (AIS ≥ 3), admitted to 24 level I and II trauma centers between January 1, 2014 to December 31, 2020 and who received subcutaneous UH and LMWH injections for chemical venous thromboembolism prophylaxis (VTEP) were included. Primary outcomes were VTE and ICHE after VTEP initiation. Secondary outcomes were mortality and neurosurgical interventions. Entropy balancing (EBAL) weighted competing risk or logistic regression models were estimated for all outcomes with chemical VTEP agent as the predictor of interest.

RESULTS

984 patients received chemical VTEP, 482 UH and 502 LMWH. Patients on LMWH more often had pre-existing conditions such as liver disease (UH vs LMWH 1.7 % vs. 4.4 %, p = 0.01), and coagulopathy (UH vs LMWH 0.4 % vs. 4.2 %, p < 0.001). There were no differences in VTE or ICHE after VTEP initiation. There were no differences in neurosurgical interventions performed. There were a total of 29 VTE events (3 %) in the cohort who received VTEP. A Cox proportional hazards model with a random effect for facility demonstrated no statistically significant differences in time to VTE across the two agents (p = 0.44). The LMWH group had a 43 % lower risk of overall ICHE compared to the UH group (HR = 0.57: 95 % CI = 0.32-1.03, p = 0.062), however was not statistically significant.

CONCLUSION

In this multi-center analysis, patients who received LMWH had a decreased risk of ICHE, with no differences in VTE, ICHE after VTEP initiation and neurosurgical interventions compared to those who received UH. There were no safety concerns when using LMWH compared to UH.

LEVEL OF EVIDENCE: Level III, Therapeutic Care Management.

Для цитирования: Ratnasekera Asanthi M, Seng Sirivan S, Kim Daniel, Ji Wenyan, Jacovides Christina L, Kaufman Elinore J, Sadek Hannah M, Perea Lindsey L, Poloni Christina Monaco, Shnaydman Ilya, Lee Alexandra Jeongyoon, Sharp Victoria, Miciura Angela, Trevizo Eric, Rosenthal Martin G, Lottenberg Lawrence, Zhao William, Keininger Alicia, Hunt Michele, Cull John, Balentine Chassidy, Egodage Tanya, Mohamed Aleem T, Kincaid Michelle, Doris Stephanie, Cotterman Robert, Seegert Sara, Jacobson Lewis E, Williams Jamie, Moncrief Melissa, Palmer Brandi, Mentzer Caleb, Tackett Nichole, Hranjec Tjasa, Dougherty Thomas, Morrissey Shawna, Donatelli-Seyler Lauren, Rushing Amy, Tatebe Leah C, Nevill Tiffany J, Aboutanos Michel B, Hamilton David, Redmond Diane, Cullinane Daniel C, Falank Carolyne, McMellen Mark, Duran Chris, Daniels Jennifer, Ballow Shana, Schuster Kevin M, Ferrada Paula. Propensity weighted analysis of chemical venous thromboembolism prophylaxis agents in isolated severe traumatic brain injury: An EAST sponsored multicenter study.. Injury. 2024. DOI: 10.1016/j.injury.2024.111523.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.